CFDRC acquisition to speed discovery of new antibiotics
A pair of HudsonAlpha companies are combining to speed the discovery of new antibiotics. CFD Research Corp. has acquired the drug discovery division of iXpressGenes; both are associate companies at Huntsville-based HudsonAlpha Institute for Biotechnology. As part of the acquisition, CFDRC obtained iXG’s high-throughput antimicrobial discovery platform called EMAD (Extremophilic Microbiome Antimicrobial Discovery) and all […]
